von Willebrand factor clearance does not involve proteolysis by ADAMTS-13

被引：16

作者：

Badirou, I. ^{[1
]}

Kurdi, M. ^{[1
]}

Rayes, J. ^{[1
]}

Legendre, P. ^{[1
,2
]}

Christophe, O. D. ^{[1
,2
]}

Lenting, P. J. ^{[1
,2
]}

Denis, C. V. ^{[1
,2
]}

机构：

[1] INSERM, U770, F-94276 Le Kremlin Bicetre, France

[2] Univ Paris Sud, UMR 770, F-94275 Le Kremlin Bicetre, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 10期

关键词：

SURVIVAL; MUTATION; MODEL;

D O I：

10.1111/j.1538-7836.2010.04012.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2338 / 2340

页数：3

共 9 条

[1]

Bowen DJ, 2003, THROMB HAEMOSTASIS, V90, P961

[2] Systemic antithrombotic effects of ADAMTS13 [J].

Chauhan, AK ;

Motto, DG ;

Lamb, CB ;

Bergmeier, W ;

Dockal, M ;

Plaimauer, B ;

Scheiflinger, F ;

Ginsburg, D ;

Wagner, DD .

JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) :767-776

[3] ADAMTS13: a new link between thrombosis and inflammation [J].

Chauhan, Anil K. ;

Kisucka, Janka ;

Brill, Alexander ;

Walsh, Meghan T. ;

Scheiflinger, Friedrich ;

Wagner, Denisa D. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (09) :2065-2074

[4] Clearance of von Willebrand factor [J].

Denis, Cecile V. ;

Christophe, Olivier D. ;

Oortwijn, Beatrijs D. ;

Lenting, Peter J. .

THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) :271-278

[5] An experimental model to study the in vivo survival of von Willebrand factor -: Basic aspects and application to the R1205H mutation [J].

Lenting, PJ ;

Westein, E ;

Terraube, V ;

Ribba, AS ;

Huizinga, EG ;

Meyer, D ;

de Groot, PG ;

Denis, CV .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12102-12109

[6] Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations [J].

Millar, Carolyn M. ;

Riddell, Anne F. ;

Brown, Simon A. ;

Starke, Richard ;

Mackie, Ian ;

Bowen, Derrick J. ;

Jenkins, P. Vincent ;

van Mourik, Jan A. .

THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) :916-924

[7] Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice [J].

Motto, DG ;

Chauhan, AK ;

Zhu, GJ ;

Homeister, J ;

Lamb, CB ;

Desch, KC ;

Zhang, WR ;

Tsai, HM ;

Wagner, DD ;

Ginsburg, D .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2752-2761

[8] Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B [J].

Rayes, Julie ;

Hollestelle, Martine J. ;

Legendre, Paulette ;

Marx, Isabelle ;

de Groot, Philip G. ;

Christophe, Olivier D. ;

Lenting, Peter J. ;

Denis, Cecile V. .

BLOOD, 2010, 115 (23) :4870-4877

[9]

Stoddart JH, 1996, BLOOD, V88, P1692

← 1 →